About this ETF
This investment vehicle aims to deliver sustained appreciation of capital over an extended period.
Description from the fund data provider · profile as of Aug 26, 2026.
Price Chart
Daily closing prices (price return, not total return). Comparison lines are normalized to percent change from the range start. Source: Financial Modeling Prep.
Performance
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | Incep.* | |
|---|---|---|---|---|---|---|---|---|---|
| Price return | +2.95% | +3.88% | +16.00% | +20.31% | — | — | — | — | +22.69% |
| Total return | +2.95% | +3.89% | +16.01% | +20.32% | — | — | — | — | +22.70% |
* Annualized. Total return uses the dividend-adjusted price series (distributions reinvested); price return uses unadjusted closes. Performance through Aug 25, 2026. Past performance does not guarantee future results.
Fees
| Net expense ratio | 0.49% | Annual cost of a $10,000 investment | $49.00 |
Illustrative calculation only: expense ratio × $10,000. It excludes trading costs, bid/ask spreads, taxes and changes in investment value. Gross vs. net expense details and any fee waivers are in the prospectus.
Holdings
Holdings as of Aug 22, 2026 — portfolio reporting date from the data provider; holdings are not live positions. 304 rows in database.
| # | Holding | Ticker | Weight | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | 10X GENOMICS INC CLASS A COMMON STOCK USD.00001 | TXG | 1.05% | 5.32K | $340.0K |
| 2 | KRYSTAL BIOTECH INC COMMON STOCK USD.00001 | KRYS | 1.01% | 975 | $328.6K |
| 3 | CECO ENVIRONMENTAL CORP COMMON STOCK USD.01 | CECO | 0.92% | 4.12K | $300.5K |
| 4 | SENSIENT TECHNOLOGIES CORP COMMON STOCK USD.1 | SXT | 0.86% | 2.11K | $280.3K |
| 5 | HEXCEL CORP COMMON STOCK USD.01 | HXL | 0.82% | 2.82K | $265.5K |
| 6 | EXPRO LTD COMMON STOCK USD.0001 | XPRO | 0.80% | 14.18K | $261.1K |
| 7 | RADNET INC COMMON STOCK USD.0001 | RDNT | 0.78% | 3.31K | $254.7K |
| 8 | PLEXUS CORP COMMON STOCK USD.01 | PLXS | 0.77% | 1.03K | $250.4K |
| 9 | QUALYS INC COMMON STOCK USD.001 | QLYS | 0.77% | 1.37K | $249.1K |
| 10 | AGILYSYS INC COMMON STOCK USD.3 | AGYS | 0.76% | 2.18K | $247.5K |
| 11 | MAGNITE INC COMMON STOCK USD.00001 | MGNI | 0.72% | 10.02K | $234.0K |
| 12 | ARGAN INC COMMON STOCK USD.15 | AGX | 0.71% | 450 | $232.5K |
| 13 | PROTAGONIST THERAPEUTICS INC COMMON STOCK… | PTGX | 0.71% | 1.54K | $232.2K |
| 14 | ESCO TECHNOLOGIES INC COMMON STOCK USD.01 | ESE | 0.71% | 811 | $230.8K |
| 15 | LIFE TIME GROUP HOLDINGS INC COMMON STOCK USD.01 | LTH | 0.70% | 5.12K | $229.0K |
| 16 | AAR CORP COMMON STOCK USD1.0 | AIR | 0.70% | 1.73K | $228.8K |
| 17 | OMADA HEALTH INC COMMON STOCK USD.001 | OMDA | 0.70% | 9.61K | $227.8K |
| 18 | HERC HOLDINGS INC COMMON STOCK USD.01 | HRI | 0.70% | 1.41K | $227.5K |
| 19 | PRAXIS PRECISION MEDICINES I COMMON STOCK… | PRAX | 0.68% | 606 | $220.9K |
| 20 | NOVANTA INC COMMON STOCK | 0VAG.L | 0.68% | 1.52K | $220.6K |
| 21 | CRINETICS PHARMACEUTICALS IN COMMON STOCK… | CRNX | 0.68% | 2.60K | $220.2K |
| 22 | ENCOMPASS HEALTH CORP COMMON STOCK USD.01 | EHC | 0.66% | 1.79K | $215.9K |
| 23 | ADAPTIVE BIOTECHNOLOGIES COMMON STOCK USD.0001 | ADPT | 0.65% | 8.29K | $211.0K |
| 24 | CHIME FINANCIAL INC CL A COMMON STOCK USD.0001 | CHYM | 0.64% | 6.55K | $209.4K |
| 25 | TRANSALTA CORP COMMON STOCK | TA.TO | 0.64% | 16.54K | $208.5K |
Click a ticker to see every ETF that owns it.
Sector Exposure
Geographic Exposure
Country weights as reported by the data provider. Developed/emerging/frontier labels follow the classification on the Methodology page. Currency hedged: No hedging indicated in the fund name.
Distributions
| Yield (TTM) | — | Paid (last 12 months) | — |
| Frequency | — | SEC yield | Not provided by our data source — see the issuer page |
| Last ex-date | — | Last payment | — |
| Growth 1Y | — | Growth 3Y / 5Y (ann.) | — / — |
No distributions in our database for this fund — it may not pay them, or history has not loaded yet.
Risk Statistics
| Volatility 1Y / 3Y | 22.02% / — | Sharpe 1Y / 3Y | 1.22 / — |
| Max drawdown 1Y / 3Y | -13.29% / — | Sortino 1Y | 1.85 |
| Beta vs S&P 500 (3Y) | 1.11 | Correlation vs S&P 500 (1Y) | 0.862 |
| Downside deviation 1Y | 14.48% | Risk-free rate used | 3.72% (3M T-bill, FRED) |
Computed by ETF Explorer from daily dividend-adjusted closes; volatility and drawdown are annualized/period figures; S&P 500 exposure proxied by SPY. As of Aug 26, 2026. Formulas →
Liquidity
| Volume today | 17.28K | Average volume | 5.17K |
| AUM | $32.5M | Premium/Discount | +0.75% |
| Bid/Ask spread | Not provided by our data source. Check your broker's quote screen; spreads are widest at the open and close. | ||
Premium/discount compares the delayed market price with the last reported NAV — an indicative figure, not the official closing premium/discount. How ETF liquidity works →
Fund Flows (estimated)
| Period | Est. net flow | % of starting AUM | AUM start → end |
|---|---|---|---|
| 1 Day | -$311.7K | -0.95% | $32.8M → $32.5M |
| 1 Week | $54.5K | +0.17% | $33.0M → $32.5M |
ETF Explorer estimate: change in reported AUM minus the market-move effect, from our own daily snapshots. Not official issuer creation/redemption data.
Official Fund Resources
External links open the issuer's site or SEC EDGAR in a new tab. The prospectus and official documents are always the authoritative source — review them before investing.
Latest News for ACSG
No articles mention this fund directly in the last 7 days — showing general ETF coverage.
Guided help: AUM is fund size. The expense ratio is the yearly cost baked into returns. NAV is the value of what the fund owns per share; the market price can sit slightly above (premium) or below (discount) it. Total return assumes distributions were reinvested. Every dataset shows its own as-of date because holdings, assets and quotes update on different schedules.
ACSG